Although different studies have revealed that visfatin overexpression and increased visfatin serum level are associated with higher Fuhrman grades and poor survival outcome in RCC patients, its potential role in carcinogenesis remains to be demonstrated [41,73,74]. This evidence concerns the gene NAMPT and renal cell carcinoma.